Equity
Common Stock
Bristol-Myers Squibb Common Stock remained flat by 0.0% to $292.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $292.00M to $292.00M. Over 5 years (FY 2020 to FY 2025), Common Stock shows relatively stable performance with a 0.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Changes are generally minimal unless there is a significant issuance of new shares or a change in par value, reflecting the core equity base.
Detailed definition
Common stock represents the par value of shares issued to shareholders, serving as the foundational equity of the compan...
Peer comparison
This is a standard line item across all public companies, representing the nominal value of equity issued.
Metric ID:
common_stockHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M | $292.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$292.00M – $292.00M
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak19+ quarters growth
Common Stock at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's common stock?
- Bristol-Myers Squibb (BMY) reported common stock of $292.00M in Q1 2026.
- How has Bristol-Myers Squibb's common stock changed year-over-year?
- Bristol-Myers Squibb's common stock decreased by 0.0% year-over-year, from $292.00M to $292.00M.
- What is the long-term trend for Bristol-Myers Squibb's common stock?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $292.00M to $292.00M.
- What does common stock mean?
- The par value of the shares held by common stockholders.